TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 180 filers reported holding TRANSMEDICS GROUP INC in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,551,067 | -33.2% | 46,595 | +2.5% | 0.00% | -25.0% |
Q2 2023 | $3,818,738 | +118678.8% | 45,472 | +7.1% | 0.00% | 0.0% |
Q1 2023 | $3,215 | +30.1% | 42,456 | +6.0% | 0.00% | +33.3% |
Q4 2022 | $2,471 | -99.8% | 40,035 | +10.6% | 0.00% | +50.0% |
Q3 2022 | $1,510,000 | +55.2% | 36,183 | +16.9% | 0.00% | +100.0% |
Q2 2022 | $973,000 | +43.3% | 30,949 | +22.8% | 0.00% | 0.0% |
Q1 2022 | $679,000 | +50.2% | 25,205 | +6.9% | 0.00% | 0.0% |
Q4 2021 | $452,000 | -43.0% | 23,584 | -1.5% | 0.00% | 0.0% |
Q3 2021 | $793,000 | +4.9% | 23,955 | +5.1% | 0.00% | 0.0% |
Q2 2021 | $756,000 | -22.3% | 22,789 | -2.8% | 0.00% | 0.0% |
Q1 2021 | $973,000 | +101.0% | 23,440 | -3.6% | 0.00% | 0.0% |
Q4 2020 | $484,000 | +63.0% | 24,326 | +13.0% | 0.00% | – |
Q3 2020 | $297,000 | -22.3% | 21,522 | +1.0% | 0.00% | -100.0% |
Q2 2020 | $382,000 | +138.8% | 21,308 | +61.1% | 0.00% | – |
Q1 2020 | $160,000 | -22.3% | 13,228 | +21.8% | 0.00% | – |
Q4 2019 | $206,000 | – | 10,857 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Roubaix Capital, LLC | 264,438 | $5,027,000 | 4.84% |
Abrams Capital Management | 3,499,859 | $66,532,000 | 2.07% |
Sandhill Capital Partners LLC | 736,175 | $13,995,000 | 1.55% |
EMERALD ADVISERS, LLC | 451,542 | $8,584,000 | 0.36% |
RTW INVESTMENTS, LP | 503,266 | $9,567,000 | 0.36% |
EMERALD MUTUAL FUND ADVISERS TRUST | 429,868 | $8,172,000 | 0.33% |
NEXT CENTURY GROWTH INVESTORS LLC | 107,045 | $2,034,000 | 0.26% |
ELEMENT CAPITAL MANAGEMENT LLC | 63,175 | $1,201,000 | 0.26% |
HAMILTON LANE ADVISORS LLC | 19,364 | $368,000 | 0.16% |
Harbour Capital Advisors, LLC | 20,900 | $397,000 | 0.15% |